12:00 AM
 | 
Jul 06, 2009
 |  BC Week In Review  |  Company News  |  Deals

Optimata, Teva deal

The companies will use Optimata's Virtual Patient technology to identify discontinued drug candidates that can be rescued or redirected for development to...

Read the full 90 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >